CA2350888A1 - Amino-cyclobut-3-ene-1,2-diones substitues en positions 4 et 3 et leur utilisation pour induire la contraction des muscles lisses - Google Patents

Amino-cyclobut-3-ene-1,2-diones substitues en positions 4 et 3 et leur utilisation pour induire la contraction des muscles lisses Download PDF

Info

Publication number
CA2350888A1
CA2350888A1 CA002350888A CA2350888A CA2350888A1 CA 2350888 A1 CA2350888 A1 CA 2350888A1 CA 002350888 A CA002350888 A CA 002350888A CA 2350888 A CA2350888 A CA 2350888A CA 2350888 A1 CA2350888 A1 CA 2350888A1
Authority
CA
Canada
Prior art keywords
carbon atoms
pharmaceutically acceptable
acceptable salt
phenyl
cyclobut
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002350888A
Other languages
English (en)
Inventor
John Anthony Butera
Douglas John Jenkins
Joseph Richard Lennox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2350888A1 publication Critical patent/CA2350888A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Abstract

La présente invention concerne amino-cyclobut-3-ene-1,2-diones substitués en position 4 et en position 3, représentés par la formule (I) dans laquelle R¿1?, R¿2?, R¿3?, R¿4?, R¿5?, A et W sont tels que définis dans le descriptif, ces composés ayant une action relaxante sur les muscles lisses.
CA002350888A 1998-12-04 1999-12-03 Amino-cyclobut-3-ene-1,2-diones substitues en positions 4 et 3 et leur utilisation pour induire la contraction des muscles lisses Abandoned CA2350888A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20601298A 1998-12-04 1998-12-04
US09/206,012 1998-12-04
PCT/US1999/028618 WO2000034230A1 (fr) 1998-12-04 1999-12-03 Amino-cyclobut-3-ene-1,2-diones substitues en positions 4 et 3 et leur utilisation pour induire la contraction des muscles lisses

Publications (1)

Publication Number Publication Date
CA2350888A1 true CA2350888A1 (fr) 2000-06-15

Family

ID=22764622

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002350888A Abandoned CA2350888A1 (fr) 1998-12-04 1999-12-03 Amino-cyclobut-3-ene-1,2-diones substitues en positions 4 et 3 et leur utilisation pour induire la contraction des muscles lisses

Country Status (6)

Country Link
EP (1) EP1135365A1 (fr)
JP (1) JP2003529532A (fr)
AU (1) AU2163500A (fr)
BR (1) BR9915899A (fr)
CA (1) CA2350888A1 (fr)
WO (1) WO2000034230A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003259547A1 (en) * 2003-07-31 2005-02-14 Hetero Drugs Limited Ezetimibe polymorphs
JP2010018795A (ja) * 2008-06-10 2010-01-28 Sumitomo Chemical Co Ltd オキソカーボン基を有する高分子
IL277071B1 (en) 2018-03-08 2024-03-01 Incyte Corp Aminopyrizine diol compounds as PI3K–y inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354763A (en) * 1993-11-17 1994-10-11 American Home Products Corporation Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
US5500442A (en) * 1994-06-10 1996-03-19 American Home Products Corporation Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants
US5482942A (en) * 1994-06-28 1996-01-09 American Home Products Corporation (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
US5726317A (en) * 1995-09-05 1998-03-10 Fuji Xerox Co., Ltd. Cyclobutenedione compounds

Also Published As

Publication number Publication date
WO2000034230A1 (fr) 2000-06-15
BR9915899A (pt) 2001-08-21
EP1135365A1 (fr) 2001-09-26
AU2163500A (en) 2000-06-26
JP2003529532A (ja) 2003-10-07

Similar Documents

Publication Publication Date Title
EP0729457B1 (fr) Diaminocyclobutene-3,4-diones en tant que depresseurs des fibres lisses
US7932275B2 (en) 2-aminopyridine compounds useful as β-secretase inhibitors for the treatment of alzheimer's disease
US6376555B1 (en) 4-substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones and analogs thereof as novel potassium channel openers
TWI304400B (en) Anthranilamides with heteroarylsulfonyl side chain
JP3397320B2 (ja) 縮合イミダゾリウム誘導体
TW200825039A (en) 4-substituted phenoxyphenylacetic acid derivatives
US5506252A (en) Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
EP1689713A1 (fr) Inhibiteurs de benzylether et benzylamino de beta-secretase pour traiter la maladie d'alzheimer
NZ566722A (en) Novel pyrimidine carboxamides
JPH10182583A (ja) 新規ヒドロキサム酸誘導体
HUT77943A (hu) 2,5-Dioxo-piperazin-származékok, eljárás előállításukra és alkalmazásuk, valamint közbenső termékei
CA2350888A1 (fr) Amino-cyclobut-3-ene-1,2-diones substitues en positions 4 et 3 et leur utilisation pour induire la contraction des muscles lisses
EP0888357A1 (fr) Derives azaspiro
JP6758374B2 (ja) Ｉｄｈ２突然変異を標的とする抗腫瘍化合物及びその使用方法
AU2006289470A1 (en) Amide derivatives as PPAR activators
JPH024739A (ja) 新規ベンゾシクロヘプテン誘導体、これらの化合物を含有する医薬、及びそれらの製造方法
MXPA01005424A (en) 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction
US6458823B1 (en) Diaminopyrazoles
US6319941B1 (en) Diaminopyrazoles
AU727217B2 (en) Heterocyclylmethylamino derivatives of cyclobutene-3,4- diones as potassium channel modulators
JP2003128548A (ja) 縮合イミダゾリウム誘導体を含む医薬組成物
US5872139A (en) Heterocyclymethylamino derivatives of cyclobutene-3,4-diones
KR100736838B1 (ko) 신규한 카테콜 ｎ-메틸히드라지드 유도체 및 그의 제조방법
WO1998014430A1 (fr) Derives de pyrimidine
KR20030055769A (ko) 신규한 카테콜 벤즈아미드 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
FZDE Dead